n the "Vaccine Strategies" figure, multiple vaccination options are presented. Select all options below which are options under consideration for the COVID-19 vaccine. A). Injection of a weakened virus B). Injection of an inactive virus. C). Injection of a related coronavirus. D). Injection of genetic material to produce viral proteins directly in the cell.

n the "Vaccine Strategies" figure, multiple vaccination options are presented. Select all options below which are options under consideration for the COVID-19 vaccine. A). Injection of a weakened virus B). Injection of an inactive virus. C). Injection of a related coronavirus. D). Injection of genetic material to produce viral proteins directly in the cell.

Biochemistry

9th Edition

ISBN:9781319114671

Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Publisher:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Chapter1: Biochemistry: An Evolving Science

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

Describe how the antigenic components of current viral vaccines are produced and describe the process that may be followed to prepare a vaccine for the “novel Coronavirus”.
b) Explain how the chimpanzee adenovirus has been genetically modified and developed as a viral vector to deliver the Oxford-Astrra Zenica Covid 19 vaccine (ChAd0x1nCoV-19/AZD1222). Include how the vaccine was developed, trialled, how the vaccine works and why a booster is needed.
You have been hired by a major pharmaceutical company to develop a new vaccine toprevent COVID-19 infection and spread.a. What is a virus? Describe the viral life cycle. (3 marks)b. Describe the difference between an antiviral drug and a vaccine. (1 mark)c. What are three qualities you would prioritize when developing this new vaccine forCOVID-19 that you would want in the end-product? (6 marks) Note: Qualities should be overarching characteristics of the developed drug, not specifics regarding various molecular mechanisms of action
1)Describe the key processes involved in vaccine manufacturing.2) Review the literature and identify the key players in the various mutants of the spikeprotein.3) How were the structures of ACE 2 and spike protein solved?4) Why is it easier to target a single mutant versus multiple mutants in the virus?5) There are several coronaviruses in the database, why is the SARS-CoV-2 sodangerous?6) Summarize the key difference in the invasion of cells by:a. HIVb. Adenovirusc. Anthraxd. SARS-CoV-2e. MERS
Antiretroviral drugs target various aspects of HIV replication and infection. Which of the following enzymes are targets of antiretroviral drugs? Select ALL that applya).reverse transcriptaseb)integrasec).ligased).proteasee).DNA polymerase
Aside from antibody-producing vaccines against spike proteins, describe at least 2 other therapeutic strategies that employ knowledge of pathways allowing viral entry into cells and/or mechanisms preventing replication of new viral particles after entry.
Aside from antibody-producing vaccines against spike proteins, describe or gicve at least 2 other therapeutic strategies that employ knowledge of pathways allowing viral entry into cells and/or mechanisms preventing replication of new viral particles after entry. 1. 2.
. a. Compare the means by which retroviral and AAVvectors deliver therapeutic genes to human cells.b. Explain the advantages and disadvantages of eachof the two viral vectors.
) List Two (2) procedures of each virus inactivation and removal in vaccine production to explain the Good Manufacturing Process and Health and Safety Procedures?
Discuss using named examples strategies that could be used to develop an effective vaccine for the zika virus
Describe the applications of BCG vaccine.
Choose all the true statements regarding coronavirus proteins. Vaccine preventable diseases include COVID-19. For coronaviruses, it is more likely to find evolving mutations in the portion of the spike protein than the nucleocapsid protein. Mutations in the genetic code for the spike protein will produce 3D changes that are more likely to affect vaccine efficacy than changes to the nucleocapsid protein code. The nucleocapsid protein interacts with viral nucleic acid specifically whereas the spike protein interacts with the host protein non-specifically.